Evidence map›Paper›PMID 34091806›Full record

ArticleInflammation2021

CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling.

Zhi-Quan Xu, Yan Ding, Xiao-Yan Huang, Wei Xiang, Xiao-Jie He

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zhi-Quan XuHainan Women and Children's Medical Center, No. 15, Longkunnan Road, Haikou, 570206, Hainan Province, People's Republic of China.
Yan DingDepartment of Dermatology, Hainan Provincial Dermatology Disease Hospital, Haikou, 570206, Hainan Province, People's Republic of China.
Xiao-Yan HuangHainan Women and Children's Medical Center, No. 15, Longkunnan Road, Haikou, 570206, Hainan Province, People's Republic of China.
Wei XiangHainan Women and Children's Medical Center, No. 15, Longkunnan Road, Haikou, 570206, Hainan Province, People's Republic of China. 13907533529@163.com.
Xiao-Jie HeInstitute of Pediatrics, The Second Xiangya Hospital, Central South University, No. 139, Renmin Middle Road, Changsha, 410011, Hunan Province, People's Republic of China. hexj7150@163.com.ORCID http://orcid.org/0000-0003-1963-695X
Central South University · CNHainan Medical University · CNHainan Provincial Hospital of Traditional Chinese Medicine · CN

Funding

Hainan Major Science and Technology Projects ZDKJ2039010Hainan special projects of Social Development 2015SF39Hainan special projects of Social Development ZDYF2018103National Natural Science Foundation of China 30560161National Natural Science Foundation of China 61562021National Natural Science Foundation of China 81060073National Natural Science Foundation of China 81260139National Natural Science Foundation of China 81560275National Natural Science Foundation of China 81960885the science foundation of young scholars of hunan province 2018JJ3753Wellcome Trust 201515
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease and a common complication of SLE is lupus nephritis (LN) during which lupus autoantibodies and proinflammatory cytokines attack the kidney and cause renal dysfunction. The current treatments to LN are limited due to a poor understanding of the pathogenesis. Here, we studied the molecular mechanisms of LN by investigating the function of circELK4/miR-27b-3p axis. MRL/lpr mice and LPS-treated HK-2 cells were used as the mouse model and cell model of LN, respectively. Blood samples were collected from LN patients. qRT-PCR and western blot were used to measure expression levels of circELK4, miR-27b-3p, apoptosis-related proteins, cytokines, and STING/IRF-3/IFN-I signaling. ELISA was performed to examine levels of cytokines including IL-6 and TNF-α. H&E staining was used to examine kidney morphology. TUNEL staining and flow cytometry were used to determine cell apoptosis. Dual luciferase activity assay and RNA pull down were employed to validate the interactions of circELK4/miR-27b-3p and miR-27b-3p/STING. CircELK4 was elevated in LN mice, patients, and LPS-treated HK-2 cells. Knockdown of circELK4 attenuated renal injury in LN mice and LPS-induced HK-2 cell injury. CircELK4 directly bound to miR-27b-3p while miR-27b-3p targeted STING. Moreover, overexpression of circELK4 could partially reverse the effects of miR-27b-3p mimics on cell apoptosis and inflammation. Furthermore, circELK4/miR-27b-3p regulated renal cell damage via modulating STING/IRF3/IFN-I signaling. CircELK4 contributes to renal injury by promoting inflammation and cell apoptosis via acting as a miR-27b-3p sponge to modulate STING/IRF3/IFN-I signaling in LN.

Indexed as

AdultAnimalsCell Lineets-Domain Protein Elk-4FemaleHEK293 CellsHumansInterferon Regulatory Factor-3Interferon Type ILupus NephritisMaleMembrane ProteinsMiceMice, Inbred MRL lprMicroRNAsMiddle AgedELK4 protein, humanets-Domain Protein Elk-4Interferon Regulatory Factor-3Interferon Type IIRF3 protein, humanMembrane ProteinsMicroRNAsMIRN27b microRNA, humanSTING1 protein, humanSTING ProteincircELK4lupus nephritismiR-27b-3pSTING/IRF3/IFN-I signaling

Identifiers

PMID34091806
OpenAlexW3170963655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.